Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCipla

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Sell BoB, Allahabad Bank; Cipla may hit Rs 542: Rajat Bose

      Rajat Bose of rajatkbose.com recommends selling Bank of Baroda and Allahabad Bank and feels that Cipla may hit Rs 542.

    • Lupin, Cipla top picks from pharma space: Parag Thakkar

      Parag Thakkar, Head of Sales at HDFC Securities is of the view that Lupin and Cipla remains top picks from the pharma space.

    • Buy United Breweries; short Cipla: Gaurav Bissa

      Gaurav Bissa of LKP Securities recommends buying United Breweries and advises shorting Cipla.

    • Super Six stocks you can bet on February 2

      Rakesh Bansal of RK Global is of the view that one may buy Infosys with target of Rs 1235.

    • Super Six short term picks for February 1

      Manas Jaiswal of manasjaiswal.com advises buying Infosys with a target of Rs 1195.

    • Buy Reliance Industries, Titan may hit Rs 377: Prakash Gaba

      Prakash Gaba of prakashgaba.com likes Reliance Industries for target of Rs 1080 and feels that Titan Company may test Rs 377.

    • Cipla top bet from pharma space, says Jai Bala

      Jai Bala of Cashthechaos.com is of the view that Cipla is the top bet from the pharma space.

    • Sell Dabur India, Adani Ports: Rajat Bose

      Rajat Bose of rajatkbose.com recommends selling Dabur India and Adani Ports.

    • Sell Cipla, Glenmark Pharma looks weak: Rajat Bose

      Rajat Bose of rajatkbose.com recommends selling Cipla and feels that Glenmark Pharma looks weak.

    • Short Cipla, says Rajat Bose

      Rajat Bose of rajatkbose.com recommends shorting Cipla.

    • Buy Cipla at around Rs 600-650: Niraj Dalal

      Niraj Dalal, Independent Market Expert is of the view that one can buy Cipla at around Rs 600-650.

    • Enter Cipla, says Rahul Mohindar

      According to Rahul Mohindar of viratechindia.com, one may enter Cipla at these levels.

    • Super Six stocks you can bet on December 30

      Manas Jaiswal of manasjaiswal.com is of the view that one may buy Britannia Industries with a target of Rs 3050.

    • Go long in Cipla, says Siddarth Bhamre

      Siddarth Bhamre of Angel Broking advises going long in Cipla.

    • Cipla may test Rs 620, Just Dial Rs 800: Bhavin Desai

      Bhavin Desai of Motilal Oswal Securities is of the view that Cipla may test Rs 620 and Just Dial may test Rs 800.

    • Buy Pidilite Ind, bullish on Kotak Bank: Parag Thakkar

      Parag Thakkar of HDFC Securities recommends buying Pidilite Industries on dips and is bullish on Kotak Mahindra Bank.

    • Look at midcap IT, pharma stocks: Sudip Bandopadhyay

      Sudip Bandopadhyay, Market Expert is of the view that one can look at midcap IT, pharma and cement stocks.

    • Buy pharma stocks on dips for long term: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy pharma stocks on dips for long term.

    • Sell Reliance Ind, DLF; buy Cipla: Rahul Mohindar

      Rahul Mohindar of viratechindia.com recommends shorting Reliance Industries and buying Cipla while he feels that Ajanta Pharma may test Rs 1100.

    • Super Six: Top chart picks for December 8

      Ashish Kyal of wavesstrategy.com advises buying Asian Paints.

    • Like Cipla, target Rs 670-675: Rahul Mohindar

      Rahul Mohindar of viratechindia.com likes Cipla with a target of Rs 670-675.

    • Cipla may test Rs 670-675 in short term: Rahul Mohindar

      Rahul Mohindar of viratechindia.com is of the view that Cipla may test Rs 670-675 in the short term.

    • Cipla may move to Rs 660-670: CA Rudramurthy

      CA Rudramurthy BV of Vachana Investments feels that Cipla may move to Rs 660-670.

    • Cipla looks weak, may test Rs 585-590: Thukral

      According to Hemant Thukral of Aditya Birla Money, Cipla is looking weak and it may slip to Rs 585-590.

    • Super Six stocks you can bet on November 16

      Sameet Chavan of Angel Broking advises buying State Bank of India with a target of Rs 258.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347